Get started
Author

Magnus M. Halldin

Observed names: M HALLDIN, M Halldin, M M Halldin, M. HALLDIN, M. Halldin, M. M. Halldin, M.M. Halldin, Magnus Halldin, Magnus M Halldin
Observed institutions: Uppsala University, University of California, San Francisco, Royal Hallamshire Hospital, Edinburgh Royal Infirmary, Karolinska Institutet, AlzeCure Pharma (Sweden), AstraZeneca (Sweden), AlzeCure Foundation
ORCID: 0000-0001-5531-4224
Observed ORCID: 0000-0001-5531-4224
OpenAlex ID: A5030049936
Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.
1986 · S Agurell, M Halldin, et al. · Pharmacological Reviews · 409
Disposition Kinetics of Ropivacaine in Humans
1989 · A. Lee, D. Fagan, et al. · Anesthesia & Analgesia · 146
Determination of Δ1‐tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography–mass spectrometry
1989 · Eva Johansson, Koidu Norén, et al. · Biomedical Chromatography · 139
The metabolic syndrome: Prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women
2006 · M. Halldin, M. Rosell, et al. · Nutrition Metabolism and Cardiovascular Diseases · 99
Prolonged apparent half-life of Δ1-tetrahydrocannabinol in plasma of chronic marijuana users
1988 · Eva Johansson, Stig Agurell, et al. · Journal of Pharmacy and Pharmacology · 80
Urinary Excretion Half-life of Δ1-Tetrahydrocannabinol-7-oic Acid in Heavy Marijuana Users after Smoking
1989 · Eva Johansson, Magnus M. Halldin · Journal of Analytical Toxicology · 74
Terminal elimination plasma half-life of ?1-tetrahydrocannabinol (?1-THC) in heavy users of marijuana
1989 · E. Johansson, M. M. Halldin, et al. · European Journal of Clinical Pharmacology · 69
Metabolism and excretion of ropivacaine in humans.
1996 · M M Halldin, E Bredberg, et al. · Drug Metabolism and Disposition · 55
Identification of in vitro metabolites of delta 1-tetrahydrocannabinol formed by human livers.
1982 · M M Halldin, M Widman, et al. · Drug Metabolism and Disposition · 42
Quantification of 4‐OH‐2,6‐Xylidine and its Conjugates in Human Urine Samples Utilising Microextraction in Packed Syringe On‐line with Liquid Chromatography and Electrospray Tandem Mass Spectrometry (MEPS‐LC‐MS/MS)
2006 · Mohamed Abdel‐Rehim, Yvonne Askemark, et al. · Journal of Liquid Chromatography & Related Technologies · 41
Involvement of Liver Carboxylesterases in the In Vitro Metabolism of Lidocaine
2002 · Stefan E.H. Alexson, Margareta Diczfalusy, et al. · Drug Metabolism and Disposition · 39
Urinary metabolites of delta 1-tetrahydrocannabinol in man.
1982 · M M Halldin, S Carlsson, et al. · PubMed · 35
Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction
2021 · Märta Dahlström, Nather Madjid, et al. · Cells · 33
PDF
Liquid chromatographic bioanalytical determination of ropivacaine, bupivacaine and major metabolites
1999 · T. Arvidsson, Y. Askemark, et al. · Biomedical Chromatography · 32
Comparative Local Anesthetic Efficacy and Pharmacokinetics of Epidurally Administered Ropivacaine and Bupivacaine in the Sheep
1997 · H FELDMAN, S DVOSKIN, et al. · Regional Anesthesia The Journal of Neural Blockade in Obstetrics Surgery & Pain Control · 32
CSF and plasma pharmacokinetics of the NMDA receptor antagonist CPP after intrathecal, extradural and i.v. administration in anaesthetized pigs
1995 · J.D. KRISTENSEN, P. HARTVIG, et al. · British Journal of Anaesthesia · 31
PDF
The battle of Alzheimer’s Disease – the beginning of the future Unleashing the potential of academic discoveries
2014 · Johan Lundkvist, Magnus M. Halldin, et al. · Frontiers in Pharmacology · 22
PDF
Toxicity of Bupivacaine and Ropivacaine in Relation to Free Plasma Concentrations in Pregnant Rats: A Comparative Study
1997 · Bengt R. G. Danielsson, M. Kiki Danielson, et al. · Pharmacology & Toxicology · 22
Lack of metabolic racemisation of ropivacaine, determined by liquid chromatography using a chiral AGP column
1995 · Torbjörn Arvidsson, Heidi Forsmo Bruce, et al. · Chirality · 19
Pragmatic Approaches to Determine the Exposures of Drug Metabolites in Preclinical and Clinical Subjects in the MIST Evaluation of the Clinical Development Phase
2014 · Johanna Haglund, Magnus M. Halldin, et al. · Chemical Research in Toxicology · 17
Metabolism of Sameridine to Monocarboxylated Products by Hepatocytes Isolated from the Male Rat
2000 · Anna-Karin Sohlenius-Sternbeck, Hans Von Euler Chelpin, et al. · Drug Metabolism and Disposition · 17
Human Urinary Excretion Profile after Smoking and Oral Administration of [14C]Δ1-Tetrahydrocannabinol*
1990 · Eva Johansson, Hampton K. Gillespie, et al. · Journal of Analytical Toxicology · 17
Further urinary metabolites of delta 1-tetrahydrocannabinol in man.
1982 · M M Halldin, L K Andersson, et al. · PubMed · 17
Topically applied novel TRPV1 receptor antagonist, ACD440 Gel, reduces evoked pain in healthy volunteers, a randomized, double‐blind, placebo‐controlled, crossover study
2024 · M. Segerdahl, M. Rother, et al. · European Journal of Pain · 15
The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs
2012 · E. Sohlberg, M.M. Halldin, et al. · Journal of Pharmacological and Toxicological Methods · 13
Works count: 58
Citation count: 1,669
H-index: 19
I10-index: 32
Year
Topic
Type